search
Back to results

Early vs Delayed Extubation After Endovascular Treatment for Acute Ischemic Stroke (EDESTROKE)

Primary Purpose

Acute Ischemic Stroke, Endovascular Treatment

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Delayed extubation
Early extubation
Sponsored by
Hospital Clinico Universitario de Santiago
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute Ischemic Stroke focused on measuring Stroke, endovascular treatment, Extubation, mechanical ventilation, functional status

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adult (age ≥ 18 years) Acute ischemic stroke due to large intracranial vessel occlusion demonstrated on CT-angiography in the following anterior circulation locations (occlusion of the internal carotid artery and/or middle cerebral artery in segments M1, M2, M3) within 24 hours of symptom onset. Patients admitted with a NIHSS neurological status ≥ 6. Patients who received endovascular treatment under general anesthesia (intubated in the interventional radiology room) with satisfactory reperfusion (TICI 2b-2c-3). Patients admitted in the intensive care unit (ICU) with mechanical ventilation. Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency. Exclusion Criteria: Patients who have not been intubated in the interventional radiology room. Pregnancy Patients who suffer bronchial aspiration prior to the endovascular procedure or during intubation. Patients who underwent the procedure under local anesthesia and sedation. Patients with functional neurological status, prior to the ischemic stroke, measured with the modified Rankin scale (mRS) of value: 3-6. Patients with vascular involvement of the posterior cerebral circulation, or intracranial haemorrhage associated with stroke. Patients who do not sign the informed consent by themselves or their relatives.

Sites / Locations

  • University Clinical Hospital of Santiago de CompostelaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Early extubation

Delayed extubation

Arm Description

Patients randomized to early extubation, will be extubated < 6 hours after endovascular treatment under general anesthesia.

Patients randomized to delayed extubation, will be extubated 6-12 hours after endovascular treatment under general anesthesia.

Outcomes

Primary Outcome Measures

Modified Ranking Scale (mRS)
Comparison of independent functional outcome as measured by the percentage of patients with a 0 to 2 on the modified Rankin Scale (mRS) at 90 days assessed by study personal blinded to the treatment (early vs delayed extubation) The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS 0 to 2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcome assessor who is blinded to the group

Secondary Outcome Measures

NIHSS (National Institutes of Health Stroke Scale)
Change in NIHSS score on day 1 and at the time of hospital discharge compared to admission to hospital. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment.The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0. NIHSS score of 42 is the worst score (severe stroke), NIHSS score of 0 is "No stroke symptoms". 0 No stroke symptoms 1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke
Modified Ranking Scale (mRS)
Comparison of independent functional outcome as measured by the percentage of patients with a 0 to 2 on the modified Rankin Scale (mRS) at the time of hospital discharge assessed by study personal blinded to the treatment (early vs delayed extubation) The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS 0 to 2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcome assessor who is blinded to the group
Hospital length of stay
Duration in days of hospital stay
Intensive Care Unit length of stay
Duration in days of ICU stay
Patients extubated in the assigned group
Percentage of patients who can be extubated in the assigned group
Number of patients with ICU complications
Complications: Pneumonia, sepsis, bacteraemia, tracheostomy, bronchial aspiration, others
Number of patients with complications associated with mechanical ventilation
Complications: Pneumonia, pneumothorax, respiratory distress, others
Number of patients with Hospital complications
Complications: Pneumonia, sepsis, others

Full Information

First Posted
April 14, 2023
Last Updated
August 3, 2023
Sponsor
Hospital Clinico Universitario de Santiago
search

1. Study Identification

Unique Protocol Identification Number
NCT05847309
Brief Title
Early vs Delayed Extubation After Endovascular Treatment for Acute Ischemic Stroke
Acronym
EDESTROKE
Official Title
Optimal Ventilation Time After Endovascular Treatment Under General Anesthesia for Acute Ischemic Stroke. A Prospective, Randomized Comparison Between Early vs Delayed Extubation
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 18, 2023 (Actual)
Primary Completion Date
September 30, 2026 (Anticipated)
Study Completion Date
December 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Clinico Universitario de Santiago

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Although older studies, most of them retrospective in design, advocated sedation over general anesthesia during endovascular treatment for acute ischemic stroke, a recent meta-analysis and randomized studies have shown that general anesthesia is associated with better functional status at 3 months compared with local anesthesia and sedation. In our center, most procedures are performed under general anesthesia, and once the procedure is complete, the patient is transferred intubated and sedated to the ICU. If the patient is hemodynamically and respiratory stable, the patient will be extubated, and will be discharged to the Neurology hospitalization floor. Several factors have been described that may influence the evolution and functional status at three months of patients who have suffered a stroke and have received endovascular treatment, such as the time between the onset of symptoms and admission to the ward for performing the procedure, the use of general anesthesia compared to sedation and local anesthesia, adequate control of blood pressure, the size of the cerebral infarct, or a worse neurological examination at the time of the procedure. In turn, several factors have been described that may influence the success of extubation in a patient who has suffered an acute ischemic stroke and who has required orotracheal intubation, such as the absence of dysarthria, the size of the infarct, the location of the infarction, the NIHSS (National Institutes of health Stroke Scale) or neurological status prior to orotracheal intubation. The investigators do not know, however, whether the time of mechanical ventilation can influence the evolution and functional status at three months of patients who have suffered a stroke and have received endovascular treatment under general anesthesia
Detailed Description
The authors do not know whether the time of mechanical ventilation can influence the evolution and functional status at three months of patients who have suffered a stroke and have received endovascular treatment under general anesthesia. The purpose of this prospective randomized study is to compare the neurological functional status at 3 months according to the modified Rankin scale (mRS), of patients with stroke who underwent endovascular intervention with satisfactory results and who underwent early extubation (< 6 hours) compared to delayed extubation (6-12 hours).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Ischemic Stroke, Endovascular Treatment
Keywords
Stroke, endovascular treatment, Extubation, mechanical ventilation, functional status

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Intervention study, prospective, randomized, parallel and blind for the end point evaluators. (Prospective Randomized, Blinded End-point))
Masking
ParticipantInvestigator
Masking Description
We will compare patients extubated before 6 hours and between 6 to 12 hours after endovascular treatment with general anesthesia for stroke. The patient will not know the hours that he was on mechanical ventilation (masking participant). Investigators evaluating the primary endpoint (mRS at three months) and other secondary endpoints will not know to which group they were randomized. Only the research physicians who treat the patient in the ICU during the first 24 hours know the assigned group.
Allocation
Randomized
Enrollment
174 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Early extubation
Arm Type
Active Comparator
Arm Description
Patients randomized to early extubation, will be extubated < 6 hours after endovascular treatment under general anesthesia.
Arm Title
Delayed extubation
Arm Type
Experimental
Arm Description
Patients randomized to delayed extubation, will be extubated 6-12 hours after endovascular treatment under general anesthesia.
Intervention Type
Other
Intervention Name(s)
Delayed extubation
Intervention Description
Patients randomized to delayed extubation, will be extubated 6-12 hours after endovascular treatment under general anesthesia.
Intervention Type
Other
Intervention Name(s)
Early extubation
Intervention Description
Patients randomized to early extubation, will be extubated < 6 hours after endovascular treatment under general anesthesia.
Primary Outcome Measure Information:
Title
Modified Ranking Scale (mRS)
Description
Comparison of independent functional outcome as measured by the percentage of patients with a 0 to 2 on the modified Rankin Scale (mRS) at 90 days assessed by study personal blinded to the treatment (early vs delayed extubation) The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS 0 to 2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcome assessor who is blinded to the group
Time Frame
90 days
Secondary Outcome Measure Information:
Title
NIHSS (National Institutes of Health Stroke Scale)
Description
Change in NIHSS score on day 1 and at the time of hospital discharge compared to admission to hospital. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment.The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0. NIHSS score of 42 is the worst score (severe stroke), NIHSS score of 0 is "No stroke symptoms". 0 No stroke symptoms 1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke
Time Frame
Approximately 1-15 days post procedure
Title
Modified Ranking Scale (mRS)
Description
Comparison of independent functional outcome as measured by the percentage of patients with a 0 to 2 on the modified Rankin Scale (mRS) at the time of hospital discharge assessed by study personal blinded to the treatment (early vs delayed extubation) The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS 0 to 2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcome assessor who is blinded to the group
Time Frame
Approximately 3-15 days post procedure
Title
Hospital length of stay
Description
Duration in days of hospital stay
Time Frame
Approximately 3-15 days post procedure
Title
Intensive Care Unit length of stay
Description
Duration in days of ICU stay
Time Frame
Approximately 1-15 days post procedure
Title
Patients extubated in the assigned group
Description
Percentage of patients who can be extubated in the assigned group
Time Frame
Post procedure within 24 hours
Title
Number of patients with ICU complications
Description
Complications: Pneumonia, sepsis, bacteraemia, tracheostomy, bronchial aspiration, others
Time Frame
Approximately 1-10 days post procedure
Title
Number of patients with complications associated with mechanical ventilation
Description
Complications: Pneumonia, pneumothorax, respiratory distress, others
Time Frame
Approximately 1-10 days post procedure
Title
Number of patients with Hospital complications
Description
Complications: Pneumonia, sepsis, others
Time Frame
Approximately 1-15 days post procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult (age ≥ 18 years) Acute ischemic stroke due to large intracranial vessel occlusion demonstrated on CT-angiography in the following anterior circulation locations (occlusion of the internal carotid artery and/or middle cerebral artery in segments M1, M2, M3) within 24 hours of symptom onset. Patients admitted with a NIHSS neurological status ≥ 6. Patients who received endovascular treatment under general anesthesia (intubated in the interventional radiology room) with satisfactory reperfusion (TICI 2b-2c-3). Patients admitted in the intensive care unit (ICU) with mechanical ventilation. Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency. Exclusion Criteria: Patients who have not been intubated in the interventional radiology room. Pregnancy Patients who suffer bronchial aspiration prior to the endovascular procedure or during intubation. Patients who underwent the procedure under local anesthesia and sedation. Patients with functional neurological status, prior to the ischemic stroke, measured with the modified Rankin scale (mRS) of value: 3-6. Patients with vascular involvement of the posterior cerebral circulation, or intracranial haemorrhage associated with stroke. Patients who do not sign the informed consent by themselves or their relatives.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Manuel Taboada, Ph.D.
Phone
0034981950674
Email
manutabo@yahoo.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Manuel Taboada, Ph.D.
Organizational Affiliation
Clinical University Hospital of Santiago de Compostela
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Manuel Rodríguez, M.D.
Organizational Affiliation
Clinical University Hospital of Santiago de Compostela
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Clinical Hospital of Santiago de Compostela
City
Santiago de Compostela
State/Province
A Coruña
ZIP/Postal Code
15866
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Manuel Taboada
Phone
Ph.D.
Email
manutabo@yahoo.es

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data types: Deidentified participant data How to access data: Requests must be sent to manutabo@yahoo.es When available: With publication Additional Information Who can access the data: Researchers whose proposed use of the data has been approved Types of analyses: For scientific purpose Mechanisms of data availability: With investigator support
IPD Sharing Time Frame
When available: With publication
IPD Sharing Access Criteria
Researchers whose proposed use of the data has been approved Types of analyses: For scientific purpose
Citations:
PubMed Identifier
26822729
Citation
Nikoubashman O, Schurmann K, Probst T, Muller M, Alt JP, Othman AE, Tauber S, Wiesmann M, Reich A. Clinical Impact of Ventilation Duration in Patients with Stroke Undergoing Interventional Treatment under General Anesthesia: The Shorter the Better? AJNR Am J Neuroradiol. 2016 Jun;37(6):1074-9. doi: 10.3174/ajnr.A4680. Epub 2016 Jan 28.
Results Reference
background
PubMed Identifier
10806150
Citation
Coplin WM, Pierson DJ, Cooley KD, Newell DW, Rubenfeld GD. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med. 2000 May;161(5):1530-6. doi: 10.1164/ajrccm.161.5.9905102.
Results Reference
background
PubMed Identifier
32065457
Citation
Fandler-Hofler S, Heschl S, Kneihsl M, Arguelles-Delgado P, Niederkorn K, Pichler A, Deutschmann H, Fazekas F, Berghold A, Enzinger C, Gattringer T. Ventilation time and prognosis after stroke thrombectomy: the shorter, the better! Eur J Neurol. 2020 May;27(5):849-855. doi: 10.1111/ene.14178. Epub 2020 Mar 17.
Results Reference
result

Learn more about this trial

Early vs Delayed Extubation After Endovascular Treatment for Acute Ischemic Stroke

We'll reach out to this number within 24 hrs